2003年畢業(yè)于山東大學(xué)臨床醫(yī)學(xué)專業(yè)，2009年先后獲得日本和歌山醫(yī)科大學(xué)及山東大學(xué)病理學(xué)博士學(xué)位，后從事博士后研究。2010年來北京大學(xué)腫瘤醫(yī)院病理科工作，主任醫(yī)師。從事病理診斷近20年，精通腫瘤的病理診斷，尤其擅長頭頸部腫瘤及婦科腫瘤病理。教學(xué)方面，每年帶教住院醫(yī)師及專業(yè)型研究生的閱片及理論授課，曾獲得院級教學(xué)管理先進(jìn)個人及優(yōu)秀專培指導(dǎo)教師等榮譽(yù)稱號?？蒲蟹较?yàn)轭^頸部腫瘤及婦科腫瘤的組織學(xué)特點(diǎn)、分子分型、腫瘤微環(huán)境及預(yù)后的關(guān)系。先后主持國家自然基金青年基金、教育部留學(xué)回國人員科研啟動基金及北京市醫(yī)管局培育計(jì)劃項(xiàng)目，發(fā)表SCI文章及國內(nèi)核心期刊30余篇。參譯病理學(xué)著作數(shù)部，包括《羅塞和阿克曼外科病理學(xué)》第10版，《軟組織腫瘤》第5版，《斯滕伯格診斷外科病理學(xué)》第6版，《術(shù)中病理診斷圖譜》第2版，《甲狀腺細(xì)針穿刺細(xì)胞學(xué)診斷與陷阱》第1版等。曾獲得北京大學(xué)醫(yī)學(xué)部優(yōu)秀住院醫(yī)師、吳秉銓病理學(xué)發(fā)展基金會2013年度優(yōu)秀中青年學(xué)者獎及2019年吳秉銓病理學(xué)發(fā)展專項(xiàng)獎學(xué)金。社會任職包括：中華醫(yī)學(xué)會病理學(xué)分會科研工作委員會委員、中國研究型學(xué)會病理學(xué)專業(yè)委員會青年委員、北京醫(yī)學(xué)會病理學(xué)分會頭頸與甲狀腺病理學(xué)組委員、北京癌癥防治學(xué)會頭頸腫瘤MDT專業(yè)委員會委員、北京乳腺病防治學(xué)會青年學(xué)術(shù)專業(yè)委員會委員等。

近5年以第一作者/并列第一作者及通訊作者發(fā)表文章：

1. Guo, Ting; Bai, Yan-Hua; Cheng, Xiao-Jing; Han, Hai-Bo; Du, Hong; Hu, Ying; Jia, Shu-Qin; Xing, Xiao-Fang; Ji, Jia-Fu; Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4. Cancer Commun (Lond), 2021, 41(3): 258-272.

2. Yanli Zhu; Wenhao Ren; Yuntao Song; Zhihui Fan; Qian Wang; Haizhu Jin; Yiyi Guo; Yanhua Bai; Cytomorphologic features as predictors of aggressiveness in patients with pT1 papillary thyroid carcinoma: a retrospective study of associations with clinicopathological parameters in 226 fine-needle aspirates. Gland Surgery, 2021, 10(1): 319-327.

3. Bai, Yanhua; Sun, Wei; Niu, Dongfeng; Yang, Xin; Diao, Xinting; Yu, Yang; Lin, Dongmei; Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement. Virchows Archiv, 2021;479(6):1079-1083.

4. Niu, Dongfeng; Bai, Yanhua; Yao, Qian; Hou, Wei; Zhou, Lixin; Huang, Xiaozheng; Zhao, Chen; Expression and Significance of AQP3 in Cutaneous Lesions. Anal Cell Pathol (Amst), 2021, 2021: 7866471.

5. Niu, Dongfeng; Bai, Yanhua; Yao, Qian; Zhou, Lixin; Huang, Xiaozheng; Zhao, Chen ; AQP2 as a diagnostic immunohistochemical marker for pheochromocytoma and/or paraganglioma. Gland Surgery,2020,9(2): 200-208.

6. Bai,Yanhua; Niu,Dongfeng; Yao, Qian; Lin, Dongmei; Kakudo, Kennichi; Updates in the advances of sporadic medullary thyroid carcinoma: from the molecules to the clinic. Gland Surg, 2020, 9(5):1847-1856.

7. Bai, Yanhua; Kakudo, Kennichi; Jung, Chan Kwon; Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification. Endocrinol Metab (Seoul), 2020, 35(4): 696-715.

8. Bai, Yanhua; Guo, Ting; Huang, Xiaozheng; Wu, Qi; Niu, Dongfeng; Ji, Xinqiang; Feng, Qin;Li, Zhongwu; Kakudo, Kennichi; In papillary thyroid carcinoma, expression by immunohistochemistry of BRAF V600E, PD-L1, and PD-1 is closely related. Virchows Archiv, 2018, 472(5): 779-787

9. Bai, Yanhua; Niu, Dongfeng; Huang, Xiaozheng; Jia, Ling; Kang, Qiang; Dou, Fangyuan; Ji,Xinqiang; Xue, Weicheng; Liu, Yiqiang; Li, Zhongwu; Feng, Qin; Lin, Dongmei; Kakudo, Kennichi; PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma. Diagnostic Pathology, 2017, 12: 72.